Researchers at Karolinska Institutet in Sweden have managed to sequence the giant genome of a salamander, the Iberian ribbed newt, which is a full six times greater than the human genome.
Amongst the early findings is a family of genes that can provide clues to the unique ability of salamanders to rebuild complex tissue, even body parts. The study is published in Nature Communications.
This is the first time that an entire newt genome has been sequenced, an achievement that can give rise to new discoveries on the amphibian’s ability to recreate brain neurons as well as entire body parts. Amongst the first findings are a multitude of copies of a certain microRNA group, which in mammals is mainly found in embryonic stem cells, but also in tumour cells.
“It will be exciting to figure out how regeneration in the adult organism re-activates embryonic genes,” says study leader Professor András Simon at Karolinska Institutet’s Department of Cell and Molecular Biology. “What’s needed now are functional studies of these microRNA molecules to understand their function in regeneration. The link to cancer cells is also very interesting, especially bearing in mind newts’ marked resistance to tumour formation.”
Even though the abundance of stem cell microRNA genes is quite surprising, it alone cannot explain how salamanders regenerate so well. Professor Simon predicts that the explanation lies in a combination of genes unique to salamanders and how other more common genes orchestrate and control the actual regeneration process.
One of the reasons why salamander genomes have not been sequenced before is its sheer size – six times bigger than the human genome in the case of the Iberian newt, which has posed an enormous technical and methodological challenge.
“It’s only now that the technology is available to handle such a large genome,” says Professor Simon. “The sequencing per se doesn’t take that long – it’s recreating the genome from the sequences that’s so time consuming.”
“We all realised how challenging it was going to be,” recounts first author Ahmed Elewa, postdoctoral fellow at the same department. “But the very fact that it was such a challenge made it all the more exciting.”
The group at Karolinska Institutet is now engaging with other researchers to discover what can be learned from the newt genome and test new hypotheses through systematic comparisons with mammals.
“We showed ten years ago that salamanders can recreate all the cells that die in Parkinson’s disease in the space of four weeks,” says Professor Simon. “We can now delve deeply into the molecular processes underlying this ability. Although we’re doing basic research, our findings can hopefully lead to the development of new regenerative strategies for humans.”
The Latest on: Regenerative medicine
- American CryoStem to Develop ATCELL(TM) Clinical Study for Duchene Muscular Dystrophy with RACEMDon April 2, 2020 at 4:43 am
EATONTOWN, NJ / ACCESSWIRE / April 2, 2020 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular ...
- China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucomaon April 2, 2020 at 4:30 am
Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's ...
- RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Onlineon April 1, 2020 at 7:06 pm
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today ...
- Global Biotechnology Firm STEMCELL Launches COVID-19 Staff Safety Appon April 1, 2020 at 5:07 pm
STEMCELL Technologies is a global biotechnology company that develops specialized cell culture media, cell isolation tools, and scientific services that are used by life sciences researchers working ...
- 5 Actually Affordable Dupes for Augustinus Bader The Creamon April 1, 2020 at 2:03 pm
You’ve probably heard celebrities, beauty editors like us or your favorite influencers praise Augustinus Bader. He’s a world-leading expert in regenerative medicine and his brand includes face and ...
- Force-induced gene up-regulation does not follow the weak power law but depends on H3K9 demethylationon April 1, 2020 at 1:32 pm
2 Laboratory for Cellular Biomechanics and Regenerative Medicine, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, ...
- Groundbreaking Technologies Fueling Novel Diagnostic & Precision Medicine Strategies, 2020 - ResearchAndMarkets.comon April 1, 2020 at 4:07 am
The "Groundbreaking Technologies Fueling Novel Diagnostic and Precision Medicine Strategies" report has been added to ResearchAndMarkets.com's offering.
- Global Regenerative Medicine Market Insights 2019-2025 | ePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelityon March 27, 2020 at 1:35 am
The report involves insightful data on the main sectors of the Global Regenerative Medicine Market. The report has segmented market, by its types and applications. Each segment has analyzed completely ...
- Future Regenerative Medicine Market Expansion Forecaston March 26, 2020 at 9:49 am
Latest Research On the Regenerative Medicine Market. The research study begins with a detailed overview of the market for the Regen ...
- Sports Medicine Market to Grow at a CAGR of 6.5% : Key Players Are Arthrex Inc, Smith & Nephew Plc, and Stryker Corporationon March 20, 2020 at 8:17 am
The sports medicine market is expected to grow from USD 6.6 billion in 2019 to USD 9.1 billion by 2024, at a CAGR of 6.5% during the forecast period. This press release was orginally distributed by ...
via Google News and Bing News